Immunovant
IMVT
#3744
Rank
A$3.99 B
Marketcap
$23.54
Share price
4.29%
Change (1 day)
-46.62%
Change (1 year)

Immunovant (IMVT) - Cash on Hand

Cash on Hand as of December 2024 : A$0.58 Billion

According to Immunovant's latest financial reports the company has A$0.58 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Immunovant - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-03-31A$0.97 B73.94%
2023-03-31A$0.56 B-14.83%
2022-03-31A$0.65 B25.15%
2021-03-31A$0.52 B222.58%
2020-03-31A$0.16 B
2018-12-31A$0.46 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.39 B-31.69%๐Ÿ‡บ๐Ÿ‡ธ USA